| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q38853492 | 11β-Prostaglandin F2α, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer |
| Q39887862 | 17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis |
| Q79303819 | 5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production |
| Q55049480 | ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens. |
| Q36467434 | Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor |
| Q43683990 | Amyloid precursor protein in human breast cancer: an androgen-induced gene associated with cell proliferation |
| Q34507441 | An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma |
| Q54498238 | Analysis of clinically relevant values of Ki-67 labeling index in Japanese breast cancer patients. |
| Q45692997 | Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer |
| Q48376604 | Androgen receptor and enzymes in lymph node metastasis and cancer reoccurrence in triple-negative breast cancer. |
| Q46732371 | Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation. |
| Q39006065 | Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes. |
| Q38326959 | Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1. |
| Q86062268 | Aryl hydrocarbon receptor in breast cancer—a newly defined prognostic marker |
| Q38728324 | Aryl hydrocarbon receptor induced intratumoral aromatase in breast cancer |
| Q44138884 | BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients |
| Q37544330 | CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance |
| Q39893366 | Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression |
| Q41582791 | Clinical significance of subtype classification in metastatic lymph nodes of breast cancer patients undergoing neoadjuvant chemotherapy |
| Q92923007 | Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells |
| Q92435535 | Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma |
| Q33873665 | Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis |
| Q80636313 | Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor |
| Q38399495 | Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma. |
| Q31144341 | Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. |
| Q44961902 | Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor |
| Q34448770 | Estrogen-responsive finger protein as a new potential biomarker for breast cancer |
| Q33231052 | Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma |
| Q39825794 | Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues |
| Q35051560 | GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor |
| Q47977198 | Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67. |
| Q34672910 | Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma |
| Q35039862 | Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer |
| Q85973765 | Immunohistochemical analysis of aromatase in metastatic lymph nodes of breast cancer |
| Q42948054 | Immunolocalization of estrogen-producing and metabolizing enzymes in benign breast disease: comparison with normal breast and breast carcinoma |
| Q38316581 | Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: possible regulator of insitu steroidogenesis |
| Q53545105 | Immunolocalization of thymidylate synthase as a favorable prognostic marker in estrogen receptor-positive breast carcinoma. |
| Q38379949 | In situ detection of estrogen receptor dimers in breast carcinoma cells in archival materials using proximity ligation assay (PLA). |
| Q35013164 | In situ production of estrogens in human breast carcinoma |
| Q38960773 | Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma. |
| Q39727915 | Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment |
| Q33814367 | Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment |
| Q31146616 | Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer |
| Q35592923 | Intracrine mechanism of estrogen synthesis in breast cancer |
| Q35713540 | Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast |
| Q46725929 | Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast |
| Q39253863 | Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma |
| Q50227670 | Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas. |
| Q52951929 | KLF15 in breast cancer: a novel tumor suppressor? |
| Q84905998 | Krüppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens |
| Q39049500 | NRF2 immunolocalization in human breast cancer patients as a prognostic factor |
| Q28292835 | Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor |
| Q34046218 | Nucleobindin 2 in human breast carcinoma as a potent prognostic factor |
| Q43038363 | Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation |
| Q59127721 | OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma |
| Q84090569 | Oestrogen-induced genes in ductal carcinoma in situ: their comparison with invasive ductal carcinoma |
| Q47577157 | Randomized trial of aromatherapy versus conventional care for breast cancer patients during perioperative periods. |
| Q54643065 | Runx2 in human breast carcinoma: its potential roles in cancer progression |
| Q91657350 | S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells |
| Q92985751 | Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling |
| Q44659446 | Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma |
| Q37148953 | TACC2 (transforming acidic coiled-coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation |
| Q39118621 | The correlation between body mass index and breast cancer risk or estrogen receptor status in Okinawan women |
| Q90603914 | The interaction between carcinoembryonic antigen-related cell adhesion molecule 6 and human epidermal growth factor receptor 2 is associated with therapeutic efficacy of trastuzumab in breast cancer |
| Q41925294 | The interplay of endocrine therapy, steroid pathways and therapeutic resistance: Importance of androgen in breast carcinoma |
| Q91626999 | The significance of lipid accumulation in breast carcinoma cells through perilipin 2 and its clinicopathological significance |
| Q38647802 | Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification. |
| Q50246934 | Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets. |
Search more.